483
Kappa Laboratories, Inc.FDA 483 - Kappa Laboratories, Inc. - June 04, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Kappa Laboratories, Inc., a contact microbiology and chemistry laboratory in Miami, revealed significant deficiencies in their quality control systems. The firm failed to adequately investigate out-of-specification results, lacked proper procedures for instrument calibration, and used uncalibrated equipment. These issues indicate a breakdown in laboratory controls and data integrity.
Open in Dashboard
ID · 6fa4e052-762b-433f-acc2-fc2ef7abd961